Ionis Pharmaceuticals licenses second antisense GI Drug to Janssen

Generics |  News | 0 Comment | 17 Nov, 2017

U.S. based Pharma Company Ionis Pharmaceuticals, Inc. has announced that it has licensed a second orally delivered Generation 2.5 antisense drug to Janssen Biotech, Inc. (Janssen)...Read more

Cue Biopharma announces research collaboration with Merck

Generics |  News | 0 Comment | 17 Nov, 2017

US based pharma company Cue Biopharma™, Inc. has announced a strategic strategic research collaboration and license agreement with Merck. Under the terms of the deal, the CUE Biologi...Read more

Generic Acticlate tablets launched by Lupin in USA

Generics |  News | 0 Comment | 06 Nov, 2017

Pharma Major Lupin announced the launch of its Doxycycline Hyclate Tablets USP, 75 mg and 150 mg after an approval from the United States Food and Drug Administration (FDA). Lupin’s ...Read more

Lupin net profit falls 31% in Q2 to Rs 455

Generics |  News | 0 Comment | 31 Oct, 2017

Pharma company Lupin reported its financial performance for the second quarter ending September 30th, 2017. The company reported net profit of Rs 662.9 in the same period of previous year....Read more

Lupin receives FDA approval for generic Axiron topical solution

Generics |  News | 0 Comment | 27 Oct, 2017

Pharma Major Lupin has received final approval for its Testosterone Topical Solution, 30 mg per actuation from the United States Food and Drug Administration (FDA) to market a generic versi...Read more

Lupin receives FDA approval for generic Lodosyn tablets and Kapvay Extended-Release tablets

Generics |  News | 0 Comment | 27 Oct, 2017

Pharma Major Lupin has announced that it has received final approval for its Carbidopa Tablets, 25 mg and Clonidine Hydrochloride Extended-Release Tablets, 0.1 mg from the United States Foo...Read more

US FDA approves Bydureon BCise by AstraZeneca for type-2 diabetes

Generics |  News | 0 Comment | 23 Oct, 2017

Biopharma company AstraZeneca has announced its US Food and Drug Administration (FDA) approved Bydureon BCise (exenatide extended-release) injectable suspension. The new for...Read more

NCD: A major public health challenge for Asia-Pacific

Generics |  News | 0 Comment | 11 Oct, 2017

Incidence of non-communicable diseases (NCDs) is on the rise, globally as well as in Asia Pacific region. Implications are far reaching too – while on one hand, it results in a loss o...Read more

Lupin receives FDA approval for generic Corgard Tablets

Generics |  News | 0 Comment | 10 Oct, 2017

Pharma Major Lupin has announced that it has received final approval for its Nadolol Tablets USP, 20 mg, 40 mg, and 80 mg from the United States Food and Drug Administration (FDA) to market...Read more

"Biomarkers can play a key role in improving diagnosis and disease management of heart failure. "

Generics |  Opinion | 0 Comment | 10 Oct, 2017

Singapore - Southeast Asia is home to 9 million heart failure patients. In Singapore alone, it accounts for around 6,000 hospitalizations. Worryingly, not only is heart failure prevalence o...Read more

Arthritis: Act before it gets Late

Generics |  News | 0 Comment | 13 Sep, 2017

Started in 1996, October 12 is recognised as the World Arthritis Day (WAD). Established by Arthritis and Rheumatism International (ARI) and supported by the European League Against Rheumati...Read more

Michigan third most preferred destination in Midwest for life science investment

Generics |  News | 0 Comment | 11 Sep, 2017

Michigan ranked third among 11 Midwest regions for the value of equity investments made in life sciences companies during the first half of 2017.  A midyear report from Cleveland-base...Read more

Eli Lilly to invest more in new medicines and drive growth

Generics |  News | 0 Comment | 08 Sep, 2017

Eli Lilly and Company has decided to streamline operations to more efficiently focus resources on developing new medicines and to improve its cost structure. Global workforce reductions, in...Read more

Lupin launches generic Benicar tablets in the US

Generics |  News | 0 Comment | 04 Sep, 2017

Pharma company Lupin Limited has announced the launch of its Olmesartan Medoxomil tablets, 5 mg, 20 mg and 40 mg having received an approval from the United States Food and Drug Administrat...Read more

U.S. FDA approves chemo group's benznidazole to treat children with Chagas disease

Generics |  News | 0 Comment | 01 Sep, 2017

Singapore – The U.S. Food and Drug Administration (FDA) approved Chemo Research's New Drug Application (NDA) for benznidazole. This is the first drug ever approved by the FDA to treat...Read more

Battlefield Acupuncture (BFA): New pain management process for the military

Generics |  News | 0 Comment | 27 Aug, 2017

Singapore -  With the pressing need for more efficient and agile pain management practices for military service personnel, Dr. Richard C. Neimtzow of Andrews Air force base d...Read more

Victoza indicated to reduce the risk of three major adverse cardiovascular events

Generics |  News | 0 Comment | 26 Aug, 2017

The U.S. Food and Drug Administration (FDA) has approved a new indication for Victoza (liraglutide) to reduce the risk of major adverse cardiovascular (CV) events, heart attack, stroke...Read more

Generic Seroquel XR tablets launched by Lupin in USA

Generics |  News | 0 Comment | 24 Aug, 2017

Lupin Limited has announced the launch of its Quetiapine Fumarate Extended-Release Tablets, 50 mg, 150 mg, 200 mg, 300 mg and 400 mg. The tablet was approval from the United States Food an...Read more